BA
BACK.US IMAC Holdings Inc
- Market cap
- USD 378.00
- P/E
- -
- P/B
- 0.54x
- ROE
- -
- Dividend yield
- 330,952.38%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2025.
Is BACK.US undervalued?
Graham numberThe Graham number of IMAC Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
IMAC Holdings Inc fundamental analysis
No fundamental analysis for IMAC Holdings Inc yet.
IMAC Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About IMAC Holdings Inc
IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennesse…
Full company profileIMAC Holdings Inc financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
IMAC Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 15.0K | 786K | 6.70M | 15.1M | 12.8M | 14.4M | 16.2M | 5.20M | 72.1K | 30.3K |
| Gross Profit | 10.7K | 723K | 5.77M | 12.6M | 11.2M | 12.8M | 14.7M | 3.85M | -233K | -422K |
| Operating Income | -219K | -915K | -3.55M | -6.19M | -6.47M | -9.95M | -9.85M | -6.38M | -5.62M | -7.52M |
| EBITDA | -397K | -823K | -2.98M | -4.50M | -3.26M | -8.39M | -10.2M | -5.95M | -5.48M | -8.31M |
| Net Income | -381K | -57.2K | -3.05M | -7.38M | -5.57M | -11.1M | -26.7M | -9.42M | -9.05M | -13.7M |
| EPS | -2.56 | -0.38 | -13 | -29 | -15 | -15 | -28 | -8.47 | -5.76 | -3.61 |
| Balance Sheet | ||||||||||
| Total Assets | 1.60M | 1.28M | 11.1M | 20.4M | 19.7M | 27.2M | 11.1M | 1.14M | 1.59M | 310K |
| Total Liabilities | 551K | 1.11M | 15.0M | 12.5M | 11.9M | 9.28M | 6.43M | 1.90M | 7.98M | 13.3M |
| Shareholders' Equity | 1.05M | 171K | -3.93M | 7.94M | 7.81M | 18.0M | 4.65M | -753K | -6.39M | -13.0M |
| Cash & Short-term Investments | 876K | 128K | 194K | 374K | 2.62M | 7.12M | 763K | 222K | 504K | 45.1K |
| Total Debt | 500K | 760K | 5.83M | 8.38M | 9.14M | 5.90M | 4.16M | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -881K | -437K | -1.81M | -4.07M | -5.99M | -7.59M | -10.3M | -2.79M | -414K | -5.15M |
| Capital Expenditure | 0.00 | 546K | 1.58M | 1.20M | 370K | 763K | 331K | 1.00 | 0.00 | 0.00 |
| Free Cash Flow | -881K | -983K | -3.39M | -5.27M | -6.36M | -8.35M | -10.6M | -2.79M | -414K | -5.15M |
| Ratios | ||||||||||
| ROE | -36.3% | -33.4% | - | -93.0% | -71.2% | -61.8% | -575.0% | - | - | - |
| ROA | -23.8% | -4.5% | -27.6% | -36.1% | -28.2% | -40.8% | -241.3% | -823.2% | -569.3% | -4,407.5% |
| Net Profit Margin | -2,538.6% | -7.3% | -45.6% | -48.8% | -43.4% | -77.2% | -165.2% | -181.2% | -12,554.9% | -45,105.6% |
| Debt to Equity | 0.48x | 4.43x | - | 1.06x | 1.17x | 0.33x | 0.89x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
IMAC Holdings Inc dividends
- Dividend yield
- 330,952.38%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2024 | USD 1.25M | 0.80 | - |
| 2023 | USD 130M | 117 | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:30 on Sep 8, 2023.
Who owns IMAC Holdings Inc
- Insiders 1.52%
- Institutions 0.00%
- Public & others 98.48%
- Shares outstanding 3.78M
- Free float 3.73M
Top funds holding BACK.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Extended Market Index | 8.60K | 0.26% | 0.00% | Feb 2025 |
| Fidelity Series Total Market Index | 2.76K | 0.08% | 0.00% | Feb 2025 |
| Fidelity Nasdaq Composite Index | 1.83K | 0.05% | 0.00% | Feb 2025 |
| Northern Trust Extended Eq Market Idx | 558.00 | 0.02% | 0.00% | Dec 2024 |
| Spartan Total Market Index Pool E | 239.00 | 0.01% | 0.00% | Feb 2025 |
| NT Ext Eq Mkt Indx Fd DC Lend T4 | 133.00 | 0.00% | 0.00% | Dec 2024 |
| NT Ext Eq Mkt Indx Fd DC Lend T3 | 133.00 | 0.00% | 0.00% | Dec 2024 |
Top institutions holding BACK.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Renaissance Technologies Corp | 13.6K | 0.40% | 0.00% | Dec 2024 |
| Geode Capital Management, LLC | 13.6K | 0.40% | +16.71% | Dec 2024 |
| XTX Topco Ltd | 11.0K | 0.33% | 0.00% | Dec 2024 |
| Advisor Group Holdings, Inc. | 8.20K | 0.24% | 0.00% | Dec 2024 |
| Tower Research Capital LLC | 2.31K | 0.07% | -46.40% | Dec 2024 |
| Newbridge Financial Services Group, Inc. | 167.00 | 0.01% | 0.00% | Dec 2024 |
| Morgan Stanley - Brokerage Accounts | 167.00 | 0.01% | 0.00% | Dec 2024 |
| JONES FINANCIAL COMPANIES LLLP | 34.00 | 0.00% | 0.00% | Dec 2024 |
| Bank of America Corp | 12.00 | 0.00% | 0.00% | Dec 2024 |
| Financial Perspectives Inc | 0.00 | 0.00% | -100.00% | Mar 2025 |
| Citadel Advisors Llc | 0.00 | 0.00% | -100.00% | Dec 2024 |
| UBS Group AG | 0.00 | 0.00% | -100.00% | Sep 2024 |
| Kestra Advisory Services, LLC | 0.00 | 0.00% | -100.00% | Sep 2024 |
| TWO SIGMA SECURITIES, LLC | 0.00 | 0.00% | -100.00% | Dec 2024 |
| Walleye Trading Advisors, LLC | 0.00 | 0.00% | -100.00% | Sep 2024 |
IMAC Holdings Inc company profile
- Company name
- IMAC Holdings Inc
- Ticker
- BACK.US
- Exchange
- USA Stocks
- Listed since
- Feb 13, 2019
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 15
- Fiscal year end
- December
- Address
- 3401 Mallory Lane, Franklin, TN, United States, 37067
- Phone
- 303 898 5896
- Website
- imacregeneration.gcs-web.com
About IMAC Holdings Inc
IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.
IMAC Holdings Inc management
2- Ms. Faith ZaslavskyCEO & President · born 1975
- Ms. Sheri F. Gardzina CPACFO & Corporate Secretary · born 1969